<DOC>
	<DOC>NCT00309036</DOC>
	<brief_summary>The trial is performed to assess efficacy and safety of a recombinant grass Pollen allergen cocktail in allergic rhinoconjunctivitis</brief_summary>
	<brief_title>Safety and Efficacy of Recombinant Grass Pollen Allergen Cocktail in the Treatment of Allergic Rhinoconjunctivitis</brief_title>
	<detailed_description />
	<criteria>Positive Skin Prick Test reaction to grass pollen Positive RAST result to grass pollen Positive Provocation Test result to grass pollen Serious chronic diseases Other relevant perennial allergies</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>March 2013</verification_date>
	<keyword>Allergy</keyword>
	<keyword>Grass pollen</keyword>
	<keyword>Recombinant</keyword>
</DOC>